JP2000510334A - 原核生物rnaポリメラーゼ自己遺伝子を利用する細胞質遺伝子発現系 - Google Patents
原核生物rnaポリメラーゼ自己遺伝子を利用する細胞質遺伝子発現系Info
- Publication number
- JP2000510334A JP2000510334A JP09539094A JP53909497A JP2000510334A JP 2000510334 A JP2000510334 A JP 2000510334A JP 09539094 A JP09539094 A JP 09539094A JP 53909497 A JP53909497 A JP 53909497A JP 2000510334 A JP2000510334 A JP 2000510334A
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- cat
- promoter
- self
- rna polymerase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
- C12N2840/206—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES having multiple IRES
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1630496P | 1996-04-26 | 1996-04-26 | |
| US60/016,304 | 1996-04-26 | ||
| PCT/US1997/007030 WO1997041243A2 (fr) | 1996-04-26 | 1997-04-25 | Systeme d'expression cytoplasmique de gene mettant en application un autogene procaryote d'arn polymerase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000510334A true JP2000510334A (ja) | 2000-08-15 |
Family
ID=21776448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP09539094A Pending JP2000510334A (ja) | 1996-04-26 | 1997-04-25 | 原核生物rnaポリメラーゼ自己遺伝子を利用する細胞質遺伝子発現系 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0910653A2 (fr) |
| JP (1) | JP2000510334A (fr) |
| AU (1) | AU2744697A (fr) |
| CA (1) | CA2250759A1 (fr) |
| WO (1) | WO1997041243A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU763325B2 (en) | 1998-01-15 | 2003-07-17 | King's College London | Ribozymal nucleic acids cleaving CCR5 or CXCR4 |
| US6342596B1 (en) * | 1998-05-05 | 2002-01-29 | Hsf Pharmaceuticals S.A. | Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| US20040142892A1 (en) * | 2001-04-30 | 2004-07-22 | The University Of British Columbia | Autogene nucleic acids encoding a secretable RNA polymerase |
| WO2002088370A2 (fr) * | 2001-04-30 | 2002-11-07 | Protiva Biotherapeutics Inc. | Acides nucleiques autogenes codants pour une polymerase d'arn secretable |
| GB0406330D0 (en) * | 2004-03-20 | 2004-04-21 | Univ Sheffield | Gene screen |
| AU2016256579B2 (en) | 2015-04-30 | 2021-08-12 | Engenes Biotech Gmbh | Uncoupling growth and protein production |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69022165T2 (de) * | 1989-10-31 | 1996-04-04 | Sagami Chem Res | Klonierungs-Plasmid-Vektor, Primer-Vektor davon und Herstellungsverfahren einer cDNA-Bank. |
| AU652566B2 (en) * | 1990-06-18 | 1994-09-01 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Eukaryotic expression vector system |
| US5591601A (en) * | 1993-05-14 | 1997-01-07 | Ohio University Edison Animal Biotechnology Institute | DNA polymerase gene expression system utilizing an RNA polymerase co-delivered with the gene expression vector system |
| CA2140081C (fr) * | 1994-01-13 | 2008-04-01 | Dean L. Engelhardt | Procede, construct et conjugue permettant de produire des copies multiples d'acides nucleiques |
-
1997
- 1997-04-25 CA CA 2250759 patent/CA2250759A1/fr not_active Abandoned
- 1997-04-25 EP EP97921403A patent/EP0910653A2/fr not_active Withdrawn
- 1997-04-25 WO PCT/US1997/007030 patent/WO1997041243A2/fr not_active Ceased
- 1997-04-25 JP JP09539094A patent/JP2000510334A/ja active Pending
- 1997-04-25 AU AU27446/97A patent/AU2744697A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2250759A1 (fr) | 1997-11-06 |
| WO1997041243A3 (fr) | 1998-02-19 |
| EP0910653A2 (fr) | 1999-04-28 |
| WO1997041243A2 (fr) | 1997-11-06 |
| AU2744697A (en) | 1997-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Guan et al. | Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems | |
| CN110714015B (zh) | 一种mRNA狂犬病疫苗 | |
| Garnett | Gene-delivery systems using cationic polymers | |
| Tanimoto et al. | No enhancement of nuclear entry by direct conjugation of a nuclear localization signal peptide to linearized DNA | |
| JP6608284B2 (ja) | 癌の治療に使用されるrnaトランススプライシング分子(rtm) | |
| JP2005529959A (ja) | 細胞へのポリヌクレオチドの伝達をするための新規な方法 | |
| JP2002502243A (ja) | トランスフェクション活性を有するインテグリン−ターゲッティングベクター | |
| WO2005035764A1 (fr) | Acides nucleiques autogenes codant un arn polymerase pouvant etre secrete | |
| Yamada et al. | Validation of the use of an artificial mitochondrial reporter DNA vector containing a Cytomegalovirus promoter for mitochondrial transgene expression | |
| JP2021519101A (ja) | ドナーdnaを連結するための改変型核酸編集システム | |
| CA2325744A1 (fr) | Fusion de liposome et vehicule d'administration | |
| JP2011504375A (ja) | 細胞の中に核酸を導入する医薬組成物及びその方法 | |
| JP2000510334A (ja) | 原核生物rnaポリメラーゼ自己遺伝子を利用する細胞質遺伝子発現系 | |
| Li et al. | Delivery of a PCR amplified DNA fragment into cells: a model for using synthetic genes for gene therapy | |
| JP2002508956A (ja) | 遺伝子送達のための方法および組成物 | |
| WO1997041243A9 (fr) | Systeme d'expression cytoplasmique de gene mettant en application un autogene procaryote d'arn polymerase | |
| JP2022173834A (ja) | 人工ウイルスキャプシド | |
| JP2025520111A (ja) | Rnaアジュバント、その方法及び使用 | |
| CN120051568A (zh) | 具有改善的活性的经修饰转运rna | |
| JP2003534804A (ja) | トランスフェクションの改良方法 | |
| WO2005054486A1 (fr) | Procede de preparation de reactif de transfert genetique | |
| EP1210122A1 (fr) | Expression de gene au moyen de polynucleotides modifies de maniere covalente | |
| JP2003504320A (ja) | 生物学的材料の送達系 | |
| US20250034548A1 (en) | Improved modular prime editing with modified effectors and templates | |
| KR102515464B1 (ko) | 핵산 또는 유전자 형질감염 효율을 개선하는 세포독성 완화 막 투과 펩타이드 및 이의 용도 |